Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Patricia Baxter
Institutions:
Baylor College of Medicine,
Texas Children's Hospital
Observed institutions:
Baylor College of Medicine,
Texas Children's Hospital
ORCID:
0000-0001-6955-7083
Observed ORCID:
0000-0001-6955-7083
OpenAlex ID:
A5128845110
Pediatric Brain Tumor Consortium Phase I Study of CD40 Agonist Sotigalimab in Pediatric and Young Adult Patients with Recurrent CNS Tumors and Newly Diagnosed DIPG
2026
·
Holly B. Lindsay
, Catherine A. Billups
, et al.
·
Clinical Cancer Research
·
2
ID #854 Updated findings from a phase 1 study of savolitinib in recurrent, progressive, or refractory medulloblastoma (MB), high-grade glioma (HGG), diffuse intrinsic pontine glioma (DIPG), and central nervous system (CNS) tumors harboring MET aberrations: A Pediatric Brain Tumor Consortium Trial: PBTC-049
2026
·
Ralph Salloum
, Clinton Stewart
, et al.
·
Neuro-Oncology Pediatrics
ID #1132 CONNECT TarGeT-A molecularly-guided phase 2 trial for children and young adults newly diagnosed with high-grade glioma (HGG), including diffuse intrinsic pontine glioma (DIPG): (1) Ribociclib and everolimus for HGG/DIPG with cell cycle and/or PI3K/mTOR pathway alterations, and (2) Ribociclib and temozolomide for diffuse hemispheric glioma (DHG), H3G34-mutant
2026
·
Margot Lazow
, Kathleen Schieffer
, et al.
·
Neuro-Oncology Pediatrics
ID #1122 Preliminary feasibility of an international, multidisciplinary central screening platform for the CONNECT TarGeT molecularly-guided phase 2 umbrella trial for children and young adults with newly-diagnosed high-grade glioma (HGG) including diffuse intrinsic pontine glioma (DIPG)
2026
·
Margot Lazow
, Kathleen Schieffer
, et al.
·
Neuro-Oncology Pediatrics
ID #1131 Predicting Early Tumor Progression in Patients with Atypical Teratoid/Rhabdoid Tumor with Longitudinal CSF Liquid Biopsies: A Report from Phase 2 Study (SJATRT) stratum B1.
2026
·
Aditi Bagchi
, Anna Kostecka
, et al.
·
Neuro-Oncology Pediatrics
ID #651 A phase 1/2 and surgical Pediatric Brain Tumor Consortium (PBTC) study evaluating the casein kinase 2 (CK2) inhibitor CX-4945 (silmitasertib sodium) in children and adults with recurrent sonic hedgehog (SHH) medulloblastoma (MB): PBTC-053
2026
·
Ralph Salloum
, Tersa Purzner
, et al.
·
Neuro-Oncology Pediatrics
ID #768 Phase I study of intravenous and intracerebroventricular C7R-GD2.CAR T cell therapy for pediatric central nervous system (CNS) tumors
2026
·
Jasia Mahdi
, Austin Stuckert
, et al.
·
Neuro-Oncology Pediatrics
Erratum: Phase I Trial of GD2.CART Cells Augmented With Constitutive Interleukin-7 Receptor for Treatment of High-Grade Pediatric CNS Tumors
2026
·
Frank Y. Lin
, Austin Stuckert
, et al.
·
Journal of Clinical Oncology
DMG-65. The Diffuse Intrinsic Glioma (DIPG) and Diffuse Midline Glioma (DMG) National Brain Tumor Board: Review of Resource Implementation and Utilization
2025
·
Greta Peng
, Rebecca Ronsley
, et al.
·
Neuro-Oncology Pediatrics
LBA-01. Tumor and systemic molecular / immune correlates and patient reported QOL in pediatric CNS and solid tumors treated with PD1 inhibition and conventional versus hypofractionated radiation on PNOC013
2025
·
Cassie Kline
, Jonathan Schoenfeld
, et al.
·
Neuro-Oncology Pediatrics
Show more works
View as search
Works count:
10
Citation count:
2
H-index:
1
I10-index:
Year
Topic
Type